No Loose Ends: A Review of the Pharmacotherapy of Hairy Cell and Hairy Cell Leukemia Variant.
CONCLUSION: HCL and HCLv are uncommon lymphoid neoplasms that lead to a characteristic constellation of symptoms. The emergence of PAs and novel targeted agents have improved the likelihood and durability of responses for these patients.
PMID: 30841702 [PubMed - as supplied by publisher]
Source: The Annals of Pharmacotherapy - Category: Drugs & Pharmacology Authors: King AC, Kabel CC, Pappacena JJ, Stump SE, Daley RJ Tags: Ann Pharmacother Source Type: research
More News: Drugs & Pharmacology | Hairy Cell Leukemia | Leukemia | Pancytopenia | Rare Diseases | Rituxan | Study